AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases

Circulation

Volumn 106, Issue 3, 2002, Pages 388-391

  Pearson, Thomas A ^a   Blair, Steven N ^a   Daniels, Stephen R ^a   Eckel, Robert H ^a   Fair, Joan M ^a   Fortmann, Stephen P ^a   Franklin, Barry A ^a   Goldstein, Larry B ^a   Greenland, Philip ^a   Grundy, Scott M ^a   Hong, Yuling ^a   Miller, Nancy Houston ^a   Lauer, Ronald M ^a   Ockene, Ira S ^a   Sacco, Ralph L ^a   Sallis Jr , James F ^a   Smith Jr , Sidney C ^a   Stone, Neil J ^a   Taubert, Kathryn A ^a  

^a NONE

Author keywords

AHA Scientific Statements; Cardiovascular disease; Prevention; Risk factors; Stroke

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA DERIVATIVE; THIAZOLIDINE DERIVATIVE; TOBACCO SMOKE; WARFARIN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET THERAPY; DIETARY INTAKE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE PERSONNEL; HEART ATRIUM FIBRILLATION; HUMAN; LIFESTYLE; LIPID BLOOD LEVEL; MEDICAL SOCIETY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; STROKE; TREATMENT CONTRAINDICATION; WEIGHT REDUCTION;

ADULT; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; HUMANS; RISK ASSESSMENT;

EID: 0037118660     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000020190.45892.75     Document Type: Review

References (37)

1. Guide to primary prevention of cardiovascular diseases: A statement for healthcare professionals from the Task Force on Risk Reduction
2. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
3. Optimal risk factors in the population: Prognosis, prevalence, and secular trends; data from Goteborg population studies
4. Low risk factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: Findings for 5 large cohorts of young adult and middle-aged men and women
5. Primary prevention of coronary heart disease in women through diet and lifestyle
6. Vitamin E supplementation and cardiovascular events in high-risk patients
7. 27th Bethesda Conference. Matching the Intensity of Risk Factor Management with the Hazard for Coronary Disease Events
8. AHA dietary guidelines: Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association
9. Alcohol and heart disease
10. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
11. Statement on exercise: Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology
12. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: Benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention
13. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report
14. Obesity and heart disease: A statement for healthcare professionals from the Nutrition Committee
15. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
16. Standards of medical care for patients with diabetes mellitus
17. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
18. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke council of the American Heart Association
19. Guide to preventive cardiology for women: AHA/ACC scientific statement consensus panel statement
20. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences
21. Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
22. Aspirin for the primary prevention of cardiovascular events: Recommendations and rationale
23. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
24. Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the U.S. Preventive Services Task Force
25. Prediction of coronary heart disease using risk factor categories
26. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
27. AHA Conference Proceedings: Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Executive summary
28. Very low fat diets
29. AHA science advisory: Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and betacarotene: A statement for healthcare professionals from the American Heart Association
30. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events